Lundbeck closes RNA deal worth USD 109m with US biotech firm
![Lundbeck Vice President Klaus Bæk Simonsen | Photo: Lundbeck / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13181619.ece/ALTERNATES/schema-16_9/doc7gyudp2jsaao94jabx6.jpg)
New treatments for rare brain diseases in a potentially very lucrative market.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Takeda surpasses analyst forecasts in Q1
For subscribers
Lundbeck to trial migraine drug in young people
For subscribers